Biotech Flashes A Bearish Signal On Mixed Alzheimer's Studies - Investor's Business Daily

Shares of dropped Monday on mixed test results for its Alzheimer's disease agitation treatment.

By: Investor's Business Daily

Dec 31 2024
0
0 Views

Shares of Axsome Therapeutics (AXSM) dropped Monday on mixed test results for its Alzheimer's disease agitation treatment. XNOW PLAYINGHow To Sell Stocks: When To Cut LossesAgitation is a common sym… [+1811 chars]

Gold prices dip as markets await fresh catalysts - Reuters

U.S. Natural Gas Futures Extend Gains - The Wall Street Journal

FAA issues launch license for Blue Origin’s New Glenn rocket - The Seattle Times

2024 Review: AI, Bitcoin, and big-tech rocked markets, but bonds frustrated many - TheStreet

Top Stock Movers Now: Boeing, MicroStrategy, EQT, and More - Investopedia

MicroStrategy Buys Bitcoin Again, Stock Falls - Investopedia

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network

all our websites